Aug 17, 2024, 15:54
Ishwaria Subbiah: The Sarah Cannon Docs commitment to advance cancer research runs deep
Ishwaria Subbiah shared a post on X:
“The Sarah Cannon Docs commitment to advance cancer research runs deep.
- Education of physicians and multidisciplinary team members is critical to sustained success of the mid- and long-term vision to broaden access to clinical trials.
- Today’s highlight – meeting with our energized internal medicine residents under chief Dr. Katherine Stockham’s leadership and discussing comprehensive symptom management to optimize both cancer and trial outcomes.
- If treatment toxicities are on your radar, then ensure your supportive care collaborator is high on your list of go-to contacts.“
Source: Ishwaria Subbiah/X
Ishwaria Subbiah is the Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research Institute (SCRI). She is also the medical director of supportive care oncology, health equity and professional well being at The US Oncology Network. Dr. Subbiah focuses on reducing cancer outcomes disparities and diversifying clinical trial participation within SCRI’s combined research network of over more than 1,300 physicians at over 250 locations in 24 states across the US.
Dr. Subbiah is a globally recognized expert in geriatric oncology, symptom management, palliative care, and healthcare professional well-being. She previously was an associate professor in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center. She is the Chair for the ASCO Women in Oncology working group and the ASCO State of Cancer Care in America initiative.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 13:05
Dec 21, 2024, 12:18
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25